Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer
Treatment for advanced gastric cancer is challenging. Epidermal growth factor receptor (EGFR) contributes to the proliferation and development of gastric cancer (GC), and its overexpression is associated with unfavorable prognosis in GC. Cetuximab, a monoclonal antibody targeting EGFR, failed to imp...
Main Authors: | Huanrong Ma PhD, Jingjing Wu Bachelor, Minyu Zhou PhD, Jianhua Wu PhD, Zhenzhen Wu PhD, Li Lin PhD, Na Huang PhD, Wangjun Liao PhD, Li Sun PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354211045349 |
Similar Items
-
RETRACTED: Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial
by: Yanqing Zheng PhD, et al.
Published: (2021-05-01) -
lncRNA ROR Promotes Gastric Cancer Drug Resistance
by: Shuai Wang PhD, et al.
Published: (2020-01-01) -
COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer
by: Xiangfei Sun PhD, et al.
Published: (2023-12-01) -
Feasibility of ERAS in Patients With Gastric Cancer Complicated by Diabetes Mellitus
by: Ying Wang PhD, et al.
Published: (2022-08-01) -
COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors
by: Maria Ödling, PhD, et al.
Published: (2024-05-01)